HealthCap
Investor profile
Investment firmVenture capital
HealthCap has backed 16 European tech companies across 22 funding rounds between 2005 and 2026, joining rounds totalling €496M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: Health Cap
Deals
22
distinct rounds
Companies
16
backed
Active span
2005–2026
22 yrs
Total round €
€496M
sum of rounds joined
Deals by year
distinct rounds / yearHealthCap — deals by year — interactive chart.
Data table
| HealthCap — deals by year | |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Top sectors
by dealsHealthCap — top sectors — interactive chart.
Data table
| HealthCap — top sectors | |
|---|---|
| Healthtech | 22 |
Stages
by dealsHealthCap — stages — interactive chart.
Data table
| HealthCap — stages | |
|---|---|
| Other | 9 |
| Series A | 6 |
| Series B | 4 |
| Growth/Late | 2 |
| Early VC | 1 |
Countries
by dealsHealthCap — countries — interactive chart.
Data table
| HealthCap — countries | |
|---|---|
| Sweden | 11 |
| Germany | 3 |
| Finland | 2 |
| France | 2 |
| Belgium | 1 |
| Denmark | 1 |
| Ireland | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Industrifonden3
- Capio2
- Expon Capital2
- Lundbeckfond Ventures2
- MassMutual Ventures (MMV)2
- Novartis Venture Fund2
- Novo Holdings2
- Swedbank Robur2
- Abingworth LLP1
- Access Biotechnology1
- Avoro Capital Advisors1
- BioMedPartners1
- Columbus Venture Partners1
- Crowberry Capital1
- Deep Track Capital1
- DVH Ventures1
- Earlybird Venture Capital1
- EQT Life Sciences1
- Fåhraeus Startup and Growth1
- Fidelity1
- Finnish Inventure1
- Forbion1
- Fountain Healthcare Partners1
- GIMV1
- Inbox Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemab Therapeutics | Denmark | 1 | €127M |
| Precirix | Belgium | 1 | €80M |
| BONESUPPORT | Sweden | 3 | €54M |
| Vivet Therapeutics | France | 1 | €38M |
| OxThera | Sweden | 2 | €35M |
| GenSight Biologics | France | 1 | €32M |
| Doctrin | Sweden | 3 | €31M |
| Priothera Limited | Ireland | 1 | €30M |
| Ariceum Therapeutics | Germany | 1 | €25M |
| CurifyLabs | Finland | 1 | €12M |
| HelloBetter | Germany | 2 | €10M |
| Positrigo | Switzerland | 1 | €7.5M |
| Oncorena | Sweden | 1 | €6.4M |
| Oncos Therapeutics | Finland | 1 | €5.0M |
| Elsa Science | Sweden | 1 | €3.9M |
| Amra Medical | Sweden | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Precirix | Series B | €80M | 2022-03 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |
| BONESUPPORT | Growth/Late | €33M | 2016-10 |
| GenSight Biologics | Series B | €32M | 2015-07 |
| Priothera Limited | Series A | €30M | 2020-10 |
| Ariceum Therapeutics | Series A | €25M | 2022-06 |
| OxThera | Other | €18M | 2005-07 |
| OxThera | Other | €17M | 2007-06 |
| BONESUPPORT | Growth/Late | €13M | 2011-06 |